Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor |
| |
Authors: | A. Campbell R. J. Baldessarini M. H. Teicher |
| |
Affiliation: | (1) The Departments of Psychiatry and Neuroscience Program, Harvard Medical School and the Mailman Research Center, 02178 Belmont, MA, USA |
| |
Abstract: | Developing rats are far more sensitive than adults to the behavioral effects of haloperidol. The present results support the hypothesis that this change may reflect age-related changes in brain responses such as alterations in drug-receptor or drug-effector mechanisms. Dose-response studies of catalepsy and ptosis were conducted in male Sprague-Dawley rats aged 30, 56, or 100 days. Resulting dose-effect curves were approximately parallel and showed rightward shifts with highly significant progressive increases of ED50. Similar developmental decreases in drug sensitivity (3–6 ×) were found following systemic (PO or IP) administration of haloperidol or the phenothiazine neuroleptic perphenazine, which differ markedly in structure, potency, distribution, and metabolism. Age-related decreases in drug sensitivity (3–4 ×) were also found using intracerebroventricular (ICV) administration of both agents in an attempt to bypass potential pharmacokinetic influences. Since the age-dependent decrease in sensitivity to both neuroleptics was found during the rising phase of drug action (1st hour) and ranked: PO>IP>ICV, some change in absorption and distribution of both drugs may occur in addition to the apparently important maturational decrease in target-organ sensitivity indicated by the responses to direct ICV injection and by the similarity of results obtained with dissimilar agents. |
| |
Keywords: | Butyrophenones Catalepsy Development Haloperidol Maturation Perphenazine Phenothiazines Ptosis Rat |
本文献已被 SpringerLink 等数据库收录! |
|